Literature DB >> 16440366

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Winnie Yeo1, Philip J Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440366     DOI: 10.1002/hep.21051

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  122 in total

Review 1.  Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy.

Authors:  Shigeru Kusumoto; Yasuhito Tanaka; Ryuzo Ueda; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2010-10-06       Impact factor: 7.527

2.  Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine.

Authors:  Shih-Hung Tsai; Ming-Shen Dai; Jyh-Cherng Yu; Ching-Liang Ho; Yeu-Chin Chen; Yi-Ying Wu; Ping-Ying Chang; Woei-Yau Kao; Tsu-Yi Chao
Journal:  Support Care Cancer       Date:  2010-10-07       Impact factor: 3.603

3.  The treatment of severe hepatitis B virus reactivation after chemotherapy.

Authors:  Xing Li; Yan-Fang Xing; Qu Lin; Min Dong; Xiang-Bo Wan; Xiang-Yuan Wu
Journal:  Nat Rev Clin Oncol       Date:  2012-05-01       Impact factor: 66.675

4.  Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.

Authors:  Jorge Méndez-Navarro; Kathleen E Corey; Hui Zheng; Lydia L Barlow; Jae Young Jang; Wenyu Lin; Hong Zhao; Run-Xuan Shao; Steven L McAfee; Raymond T Chung
Journal:  Liver Int       Date:  2010-08-25       Impact factor: 5.828

Review 5.  When treating cancer, please don't forget hepatitis B.

Authors:  Lindsay Y King; Raymond T Chung
Journal:  Oncologist       Date:  2010-07-20

Review 6.  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors:  Harrys A Torres; Marta Davila
Journal:  Nat Rev Clin Oncol       Date:  2012-01-24       Impact factor: 66.675

7.  Consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Authors:  J S Smolen; E C Keystone; P Emery; F C Breedveld; N Betteridge; G R Burmester; M Dougados; G Ferraccioli; U Jaeger; L Klareskog; T K Kvien; E Martin-Mola; K Pavelka
Journal:  Ann Rheum Dis       Date:  2006-10-26       Impact factor: 19.103

8.  Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation.

Authors:  Cinzia Lo Giudice; Marina Martinengo; Paolo Pietrasanta; Laura Bocciardo; Cristina Malavasi; Simona Rastelli; Maura Faraci; Gino Tripodi
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

9.  Reactivation of hepatitis B: pathogenesis and clinical implications.

Authors:  Anthony Post; Shweta Nagendra
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

10.  Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.

Authors:  David Ritchie; Richard L Piekarz; Piers Blombery; Laszlo J Karai; Stefania Pittaluga; Elaine S Jaffe; Mark Raffeld; John E Janik; H Miles Prince; Susan E Bates
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.